114 related articles for article (PubMed ID: 10793029)
1. Gender-dependent effect of L-NAME on polycystic kidney disease in Han:SPRD rats.
Yoshida I; Bengal R; Torres VE
Am J Kidney Dis; 2000 May; 35(5):930-6. PubMed ID: 10793029
[TBL] [Abstract][Full Text] [Related]
2. Endothelial-derived vasoactive mediators in polycystic kidney disease.
Al-Nimri MA; Komers R; Oyama TT; Subramanya AR; Lindsley JN; Anderson S
Kidney Int; 2003 May; 63(5):1776-84. PubMed ID: 12675853
[TBL] [Abstract][Full Text] [Related]
3. Contractility and endothelium-dependent relaxation of resistance vessels in polycystic kidney disease rats.
Wang D; Iversen J; Strandgaard S
J Vasc Res; 1999; 36(6):502-9. PubMed ID: 10629426
[TBL] [Abstract][Full Text] [Related]
4. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
Pey R; Bach J; Schieren G; Gretz N; Hafner M
In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
[TBL] [Abstract][Full Text] [Related]
5. Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats.
Aukema HM; Housini I
Kidney Int; 2001 Jan; 59(1):52-61. PubMed ID: 11135057
[TBL] [Abstract][Full Text] [Related]
6. The expression and activity of renal nitric oxide synthase and circulating nitric oxide in polycystic kidney disease rats.
Wang D; Braendstrup O; Larsen S; Horn T; Strandgaard S
APMIS; 2004 Jun; 112(6):358-68. PubMed ID: 15511273
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B
Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069
[TBL] [Abstract][Full Text] [Related]
8. Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats.
Torres VE; Bengal RJ; Nickander KK; Grande JP; Low PA
Am J Kidney Dis; 1998 Apr; 31(4):687-93. PubMed ID: 9531187
[TBL] [Abstract][Full Text] [Related]
9. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.
D'Amours M; Lebel M; Grose JH; Larivière R
Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660
[TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide deficiency in the development of hypertension in hydronephrotic animals.
Carlström M; Brown RD; Edlund J; Sällström J; Larsson E; Teerlink T; Palm F; Wåhlin N; Persson AE
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F362-70. PubMed ID: 18032548
[TBL] [Abstract][Full Text] [Related]
11. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
[TBL] [Abstract][Full Text] [Related]
12. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.
Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ
Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity.
Ghaznavi R; Kadkhodaee M
Arch Toxicol; 2007 Jun; 81(6):453-7. PubMed ID: 17039356
[TBL] [Abstract][Full Text] [Related]
14. Effect of inhibition of nitric oxide synthase on blood pressure and renal sodium handling in renal denervated rats.
Xavier F; Magalhães AM; Gontijo JA
Braz J Med Biol Res; 2000 Mar; 33(3):347-54. PubMed ID: 10719388
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.
Martin PY; Ohara M; Gines P; Xu DL; St John J; Niederberger M; Schrier RW
J Clin Invest; 1998 Jan; 101(1):235-42. PubMed ID: 9421486
[TBL] [Abstract][Full Text] [Related]
16. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.
Wang X; Zhang S; Liu Y; Spichtig D; Kapoor S; Koepsell H; Mohebbi N; Segerer S; Serra AL; Rodriguez D; Devuyst O; Mei C; Wüthrich RP
Kidney Int; 2013 Nov; 84(5):962-8. PubMed ID: 23715121
[TBL] [Abstract][Full Text] [Related]
17. The effect of chloroquine on renal function and vasopressin secretion: a nitric oxide-dependent effect.
Ahmed MH; Ashton N; Balment RJ
J Pharmacol Exp Ther; 2003 Jan; 304(1):156-61. PubMed ID: 12490586
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide-inhibitory effect of aminoguanidine on renal function in rats.
Waz WR; Van Liew JB; Feld LG
Kidney Blood Press Res; 1997; 20(4):211-7. PubMed ID: 9398025
[TBL] [Abstract][Full Text] [Related]
19. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
Takeuchi K; Takehara K; Kato S
J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of oral L-arginine administration on gentamicin-induced renal failure in rats.
Can C; Sen S; Boztok N; Tuglular I
Eur J Pharmacol; 2000 Mar; 390(3):327-34. PubMed ID: 10708741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
